Predict your next investment

HEALTHCARE | Biotechnology
prochon.com

See what CB Insights has to offer

Executives

2

Board of Directors

1

ProChon Biotech Board of Director

1 Board of directors

ProChon Biotech has 1 board of directors, including Eli Hazum.

Name

Firm

Work History

Other Seats

Eli Hazum

Prof. Eli Hazum General Partner Eli joined Medica in 1995, bringing diverse expertise from both the healthcare industry and academia. Prior to joining Medica, Eli spent 5 years at Glaxo Inc. in Research Triangle Park, NC, as Head of the Department of Receptor Research and Metabolic Diseases, and as a member of the Corporate Committee for New Technology Identification, worldwide in osteoporosis. Upon returning to Israel, Eli served in various executive research and development positions at Biotechnology General Corp. (Savient) and as VP R&D at Peptor Ltd. Over the last 15 years Eli has taken leadership roles within Medica portfolio companies including interim CEO for Collgard Biopharmaceuticals and Esther Neurosciences, where he was responsible for executing Ester�s acquisition by Amarin Pharmaceuticals.Eli received his Ph.D. degree from the Weizmann Institute of Science in 1978 based on research in the field of hormone biochemistry,and has an executive MBA from Humberside University in the UK. He is the author of more than 100 scientific publications and patents in various areas of drug development.

ProChon Biotech

Name

Eli Hazum

Firm

Work History

Prof. Eli Hazum General Partner Eli joined Medica in 1995, bringing diverse expertise from both the healthcare industry and academia. Prior to joining Medica, Eli spent 5 years at Glaxo Inc. in Research Triangle Park, NC, as Head of the Department of Receptor Research and Metabolic Diseases, and as a member of the Corporate Committee for New Technology Identification, worldwide in osteoporosis. Upon returning to Israel, Eli served in various executive research and development positions at Biotechnology General Corp. (Savient) and as VP R&D at Peptor Ltd. Over the last 15 years Eli has taken leadership roles within Medica portfolio companies including interim CEO for Collgard Biopharmaceuticals and Esther Neurosciences, where he was responsible for executing Ester�s acquisition by Amarin Pharmaceuticals.Eli received his Ph.D. degree from the Weizmann Institute of Science in 1978 based on research in the field of hormone biochemistry,and has an executive MBA from Humberside University in the UK. He is the author of more than 100 scientific publications and patents in various areas of drug development.

Other Seats

ProChon Biotech

ProChon Biotech Management Team

2 Team Members

ProChon Biotech has 2 executives. ProChon Biotech's former Chief Executive Officer, President is Patrick O'Donnell.

Name

Work History

Title

Status

Patrick O'Donnell

Chief Executive Officer, President

Former

Patrick O'Donnell

Chief Executive Officer

Former

Name

Patrick O'Donnell

Patrick O'Donnell

Work History

Title

Chief Executive Officer, President

Chief Executive Officer

Status

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.